{
  "id": 9557574,
  "title": "Molecular context of pathogenic variants is associated with phenotype and treatment response in SCN8A-related disorders",
  "url": "https://urgent.news/2026/09/24/molecular-context-of-pathogenic-variants-is-associated-with-phenotype",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-24T00:00:00.000Z",
  "source": {
    "name": "bioRxiv",
    "slug": "biorxiv",
    "url": "https://www.biorxiv.org/content/10.64898/2026.09.22.753542v1?rss=1"
  },
  "original_language": "en",
  "account": "In a study exploring the genotype-phenotype relationship in SCN8A-related disorders (SCN8A-RD), researchers sought to determine if clinical heterogeneity could be explained by molecular factors beyond the specific genetic alteration. Utilizing data from the International SCN8A Registry, they mapped various molecular features against clinical phenotypes, including seizures, developmental disabilities, and treatment responses.\n\nThe researchers identified \"hot-spots\" across the coding sequence associated with different seizure types and severity of developmental disabilities. They then conducted enrichment analysis to determine if certain clinical features were more likely to appear near specific molecular sites, such as those related to post-translational modifications (PTM) and protein structure. This analysis revealed distinct enrichment profiles for developmental, seizure, and medication-response features along the coding sequence.\n\nFurthermore, the study identified 14 variants that are likely to alter RNA splicing, suggesting these missense variants could serve as potential targets for splice-directed therapy. The findings provide a higher-resolution map of pathogenic variation in SCN8A, demonstrating that seizure types, developmental severity, and medication response are organized regionally along the coding sequence. This regional organization may also explain differential drug responses, including a relationship between glycosylation and gabapentin efficacy. Ultimately, these results highlight the importance of considering molecular context when studying SCN8A-RD and suggest avenues for future research and therapeutic interventions.",
  "summary": "Objectives: Genotype-phenotype studies in rare epilepsies typically relate a pathogenic DNA sequence change to clinical outcome, without considering the broader molecular context of a given variant. Here we ask whether clinical heterogeneity in SCN8A-related disorders (SCN8A-RD) is patterned along molecular dimensions that go beyond the specific genetic alteration, to include position in the…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}